UV Flu Technologies, Inc. is a developer, manufacturer, and distributor of biotechnology products targeting the rapidly growing Indoor Air Quality (IAQ) industry. The Company manufactures the ViraTech™ UV-400 air purification system. With corporate headquarters in Centerville, Massachusetts, UV Flu Technologies, Inc. trades on the OTC Bulletin Board.
The Company’s flagship ViraTech™ UV-400 disinfects indoor air by deactivating allergens and killing airborne pathogens including bacteria, viruses and mold. The ViraTech™ UV-400 uses high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber.
Extensive independent testing by EPA and FDA certified laboratories confirms the proprietary system captures and kills airborne bacteria including Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumonia and viruses at rates exceeding 99.2 percent on a first-pass basis. The FDA has issued a Class II medical listing that enables UV Flu Technologies to market the product as a medical device.
The design of the ViraTech™ UV-400 is for numerous indoor applications where viral bacteria may be regularly present in both consumer and institutional applications. The U.S. IAQ market generated $7.7 billion in 2008. The equipment segment accounted for $3.6 billion. There is significant interest and growth in the IAQ sector because of the continuing attention given to the health effects of toxic mold, Sick Building Syndrome, antibiotic resistant superbugs, tuberculosis, the outbreak of infectious diseases such as swine flu, and the increase in chronic respiratory diseases such as asthma.
The Company announced in January of this year that they entered into an exclusive agreement with Puravair, LLC of Boston, Massachusetts to represent the Company as the North American Master Distributor for their FDA approved and patented germicidal air purification product, ViraTech™ UV-400. The agreement with Puravair includes logistics management of the product from the point of manufacture to the consumer.
On September 22, 2010, UV Flu Technologies, Inc. announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign. This campaign is to inform the public how their ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
A couple days later, UV Flu Technologies, Inc. announced that the Company and their UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be released nationally during the fourth quarter. The show, to air on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment